Pure Biologics Spólka Akcyjna (PUR) — Long-term Investment Intensity
Pure Biologics Spólka Akcyjna (PUR) has a Long-term Investment Intensity of 0.0% as of September 2022. Long-term investments of zł15.00 represent 0.0% of total assets of zł30.26 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Pure Biologics Spólka Akcyjna reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Pure Biologics Spólka Akcyjna Long-term Investment Intensity (2021–2021)
This chart shows how Pure Biologics Spólka Akcyjna's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the intensity stands at 0.0%, reflecting long-term investments of zł15.00 against total assets of zł30.26 Million PLN. Explore Pure Biologics Spólka Akcyjna (PUR) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Pure Biologics Spólka Akcyjna (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Pure Biologics Spólka Akcyjna from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Pure Biologics Spólka Akcyjna stock valuation.
| Year | LT Investment Intensity | LT Investments (PLN) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.0% | zł15.00 | zł47.19 Million | — |